Skip to content

Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)

A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot)

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01206166
Acronym
TOP-UP
Enrollment
125
Registered
2010-09-21
Start date
2011-06-30
Completion date
2015-07-31
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Critical Illness

Keywords

Randomized trial, Parental nutrition, Enteral nutrition, Intensive care unit, BMI < 25 or ≥ 35

Brief summary

The specific aim of the proposed study is to conduct a pilot study involving 160 critically-ill lean and obese patients enrolled at 11 sites in Canada, the United States of America, Belgium and France in order to: Specific Aims * Confirm that we can achieve a clinically significant difference in calorie and protein intake between the two intervention groups. * Estimate recruitment rate i.e. number of eligible and enrolled patients per month per site. * Evaluate the safety, tolerance, and logistics around providing supplemental PN in the study population in the context of a multicenter trial, e.g. * To ensure adequate glycemic control in both groups. * To ensure that the other metabolic consequences of the feeding strategies are minimized. * To establish adequate compliance with study protocols and completion of case report forms A secondary aim of this pilot study will be: • To explore the effect of differential effects of calorie and protein delivery on muscle and mass function.

Detailed description

Background Critically ill patients are often hypermetabolic and can rapidly become nutritionally compromised. Malnutrition is prevalent in these patients and has been associated with increased morbidity and mortality. Standard nutrition therapy, i.e. provision of calories, protein and other nutrients consists primarily of enteral nutrition (via a feeding tube into the gastrointestinal tract), parenteral nutrition (via an intravenous tube into the blood), or occasionally a combination of both. However, the provision of nutrition is sub-optimal and the majority of critically-ill patients do not meet nutritional requirements. Recent studies report that average energy intakes of critically ill patients are only 49% to 70% of calculated requirements. Despite repeated, sustained efforts over the past few years, the investigators have not significantly improved the amount of calories delivered via the enteral route. This leads us to conclude that if the investigators are to be successful at increasing the provision of calories and protein to patients at-risk, the investigators will have to supplement the calories via the parenteral route. Critically ill patients that are at extremes of weight are at a higher nutritional risk and have higher mortality rates. A recent International multicenter observational study of 2772 ICU patients from 165 ICUs showed a significant inverse linear relationship between the odds of mortality and total daily calories received. Increased amounts of calories was most important for the BMI \< 20 group followed by the BMI 20 -\< 25 group and BMI \> 35 group with no benefit of increased calorie intake for patients in the BMI 25 -\< 35 group. Feeding an additional 1000 kcals almost halved the odds of 60-day mortality in patients with a BMI \< 25 or \> 35. Similar results were observed for feeding an additional 30 grams of protein per day. Thus, a prospective randomized trial is warranted to confirm our hypothesis that in patients with a BMI of \< 25 and those with a BMI \> 35 increasing the provision of more energy and protein can impact clinical outcomes. The results of this study will serve to answer some fundamental questions with regards to impact of amount of energy and protein delivered to nutritional at-risk ICU patients and will inform current practice. Study Intervention: Patients will be randomized to one of 2 interventions: enteral nutrition alone or enteral nutrition plus parenteral nutrition (supplemental PN group).

Interventions

DRUGOlimel (5.7%E / N9E)

OLIMEL(Amino Acids, Dextrose, Lipids, with / without Electrolytes) is indicated for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
Clinical Evaluation Research Unit at Kingston General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill adult patient (≥ 18 years) admitted to ICU * Has acute respiratory failure (ARF) i.e. expected to remain mechanically ventilated for more than 48 hours * Expected ICU dependency of 5 or more days * On or expected to initiate enteral nutrition within 7 days of ICU admission * BMI \<25 or ≥ 35 based on pre-ICU actual or estimated dry weight

Exclusion criteria

* \>72 hours from admission to ICU to time of consent * Not expected to survive an additional 48 hrs from screening evaluation * A lack of commitment to full aggressive care (anticipated withholding or withdrawing treatments in the first week but isolated DNR acceptable) * Patients already receiving PN at screening * Absence of All gastrointestinal risk factors, defined as: 1. High Apache II Score (\>20) 2. On more than 1 vasopressor or increasing doses or vasopressors 3. Receiving continuous infusion of narcotics 4. High nasogastric/orogastric output (\>500 mL over 24 hours) 5. Recent surgery involving esophagus, stomach, or small bowel OR peritoneal contamination with bowel contents 6. Pancreatitis 7. Multiple gastrointestinal investigations 8. Recent history of diarrhea/C. Difficile 9. Surgical patients with future surgeries planned 10. Ruptured or dissected abdominal aortic aneurysm * Patients admitted with diabetic ketoacidosis or non-ketotic hyperosmolar coma * Pregnant or lactating patients * Patients with clinical fulminant hepatic failure * Patients with Cirrhosis Child's Class C Liver Disease (except those on a transplant list or transplantable) * Dedicated port of central line not available * Known allergy to study nutrients (soy, eggs or olive products) * Enrolment in another industry sponsored ICU intervention study

Design outcomes

Primary

MeasureTime frameDescription
Calorie & Protein Intake 7 Days Post Randomization7 days post randomizationAmount of calories & protein received as a percentage of prescribed.
Calorie & Protein Intake in First 27 Daysfirst 27 daysAmount of calories & protein received as a percentage of prescribed.

Secondary

MeasureTime frameDescription
Hospital Mortality6 months
Duration of ICU Stay6 months
Duration of Hospital Stay6 months
Duration of Mechanical Ventilation6 months
Development of ICU-acquired InfectionsICU discharge
SF36-Physical Functioning Domain3 monthsThe SF-36 physical function domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Physical Functioning Domain6 monthsThe SF-36 physical function domain ranges from 0-100. Higher scores indicate better outcome.
Functional Status at Hospital Dischargehospital discharge
SF36 Role Physical Domain3 monthsThe SF-36 role physical function domain ranges from 0-100. Higher scores indicate better outcome.
SF36 Pain Index Domain3 monthsThe SF-36 pain index domain ranges from 0-100. Higher scores indicate better outcome.
SF36 General Health Perceptions Domain3 monthsThe SF-36 general health perceptions domain ranges from 0-100. Higher scores indicate better outcome.
SF36 Vitality Domain3 monthsThe SF-36 vitality domain ranges from 0-100. Higher scores indicate better outcome.
SF36 Social Functioning Domain3 monthsThe SF-36 social functioning domain ranges from 0-100. Higher scores indicate better outcome.
6 Month Mortality6 monthsKaplan-Meier estimate.
SF36 Mental Health Index Domain3 monthsThe SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.
SF36 Standardized Physical Component Scale3 monthsThe SF36 Standardized Physical Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.
SF36 Standardized Mental Component Scale3 monthsThe SF36 Standardized Mental Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.
SF-36 Role-physical Domain6 monthsThe SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Pain Index Domain6 monthsThe SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 General Health Perceptions Domain6 monthsThe SF-36 general health perceptions domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Vitality Domain6 monthsThe SF-36 vitality domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Social Functioning Domain6 monthsThe SF-36 social functioning domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Role-emotional Domain6 monthsThe SF-36 role-emotional domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Mental Health Index Domain6 monthsThe SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.
SF-36 Standardized Physical Component Scale6 monthsThe SF36 Standardized Physical Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.
SF-36 Standardized Mental Component Scale6 monthsThe SF36 Standardized mental Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.
SF36 Role-emotional Domain3 monthsThe SF-36 role-emotion domain ranges from 0-100. Higher scores indicate better outcome.
ICU Mortality6 months

Countries

Belgium, Canada, France, United States

Participant flow

Participants by arm

ArmCount
Enteral Nutrition + Parenteral Nutrition
Enteral nutrition with the addition of parenteral supplementation (Olimel 5.7%E/N9E). Olimel (5.7%E / N9E): OLIMEL(Amino Acids, Dextrose, Lipids, with / without Electrolytes) is indicated for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.
73
Enteral Nutrition Only
Enteral nutrition only - no intervention
52
Total125

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyNo evaluable data23

Baseline characteristics

CharacteristicEnteral Nutrition + Parenteral NutritionEnteral Nutrition OnlyTotal
Age, Continuous55.1 years
STANDARD_DEVIATION 16.2
55.8 years
STANDARD_DEVIATION 19.8
55.45 years
STANDARD_DEVIATION 18
Race/Ethnicity, Customized
Black or African American
4 Participants2 Participants6 Participants
Race/Ethnicity, Customized
Native
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Native Hawaiian or Pacific Islander
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
unknown/unreported
0 Participants4 Participants4 Participants
Race/Ethnicity, Customized
White
65 Participants46 Participants111 Participants
Sex: Female, Male
Female
34 Participants31 Participants65 Participants
Sex: Female, Male
Male
39 Participants21 Participants60 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Calorie & Protein Intake 7 Days Post Randomization

Amount of calories & protein received as a percentage of prescribed.

Time frame: 7 days post randomization

Population: ICU patients

ArmMeasureGroupValue (MEAN)Dispersion
EN OnlyCalorie & Protein Intake 7 Days Post Randomizationcalories in first 7 days69 percentage of prescribedStandard Deviation 28
EN OnlyCalorie & Protein Intake 7 Days Post Randomizationprotein in first 7 days64 percentage of prescribedStandard Deviation 26
Enteral Nutrition + Parenteral NutritionCalorie & Protein Intake 7 Days Post Randomizationcalories in first 7 days95 percentage of prescribedStandard Deviation 13
Enteral Nutrition + Parenteral NutritionCalorie & Protein Intake 7 Days Post Randomizationprotein in first 7 days86 percentage of prescribedStandard Deviation 16
Primary

Calorie & Protein Intake in First 27 Days

Amount of calories & protein received as a percentage of prescribed.

Time frame: first 27 days

Population: ICU patients

ArmMeasureGroupValue (MEAN)Dispersion
EN OnlyCalorie & Protein Intake in First 27 Dayscalories in first 27 days72 percentage of prescribedStandard Deviation 25
EN OnlyCalorie & Protein Intake in First 27 Daysprotein in first 27 days68 percentage of prescribedStandard Deviation 25
Enteral Nutrition + Parenteral NutritionCalorie & Protein Intake in First 27 Dayscalories in first 27 days90 percentage of prescribedStandard Deviation 16
Enteral Nutrition + Parenteral NutritionCalorie & Protein Intake in First 27 Daysprotein in first 27 days82 percentage of prescribedStandard Deviation 19
Secondary

6 Month Mortality

Kaplan-Meier estimate.

Time frame: 6 months

ArmMeasureValue (NUMBER)
EN Only6 Month Mortality27.5 percentage of participants
Enteral Nutrition + Parenteral Nutrition6 Month Mortality29.5 percentage of participants
Secondary

Development of ICU-acquired Infections

Time frame: ICU discharge

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EN OnlyDevelopment of ICU-acquired Infections23 Participants
Enteral Nutrition + Parenteral NutritionDevelopment of ICU-acquired Infections14 Participants
Secondary

Duration of Hospital Stay

Time frame: 6 months

ArmMeasureValue (MEDIAN)
EN OnlyDuration of Hospital Stay24 days
Enteral Nutrition + Parenteral NutritionDuration of Hospital Stay23.5 days
Secondary

Duration of ICU Stay

Time frame: 6 months

ArmMeasureValue (MEDIAN)
EN OnlyDuration of ICU Stay12.6 days
Enteral Nutrition + Parenteral NutritionDuration of ICU Stay12.8 days
Secondary

Duration of Mechanical Ventilation

Time frame: 6 months

ArmMeasureValue (MEDIAN)
EN OnlyDuration of Mechanical Ventilation8.3 days
Enteral Nutrition + Parenteral NutritionDuration of Mechanical Ventilation6.5 days
Secondary

Functional Status at Hospital Discharge

Time frame: hospital discharge

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
EN OnlyFunctional Status at Hospital Dischargehand gripPt died17 Participants
EN OnlyFunctional Status at Hospital Dischargehand gripUnable to do12 Participants
EN OnlyFunctional Status at Hospital Dischargehand gripRefused to do3 Participants
EN OnlyFunctional Status at Hospital Dischargehand gripDone22 Participants
EN OnlyFunctional Status at Hospital Dischargehand gripMissed16 Participants
EN OnlyFunctional Status at Hospital Dischargehand gripUnknown reason1 Participants
EN OnlyFunctional Status at Hospital Dischargehand gripuse ICU2 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testPt died17 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testUnable to do31 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testRefused to do3 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testDone9 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testMissed12 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testUnknown reason1 Participants
EN OnlyFunctional Status at Hospital Discharge6min walk testuse ICU0 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testDone9 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripPt died8 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testPt died8 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripUnable to do5 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testUnknown reason3 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripRefused to do3 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testUnable to do20 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripDone17 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testMissed9 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripMissed12 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testRefused to do3 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripUnknown reason4 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Discharge6min walk testuse ICU0 Participants
Enteral Nutrition + Parenteral NutritionFunctional Status at Hospital Dischargehand gripuse ICU3 Participants
Secondary

Hospital Mortality

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EN OnlyHospital Mortality17 Participants
Enteral Nutrition + Parenteral NutritionHospital Mortality8 Participants
Secondary

ICU Mortality

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EN OnlyICU Mortality13 Participants
Enteral Nutrition + Parenteral NutritionICU Mortality7 Participants
Secondary

SF-36 General Health Perceptions Domain

The SF-36 general health perceptions domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 General Health Perceptions Domain50.9 score on a scaleStandard Deviation 20.6
Enteral Nutrition + Parenteral NutritionSF-36 General Health Perceptions Domain56.8 score on a scaleStandard Deviation 26.2
Secondary

SF36 General Health Perceptions Domain

The SF-36 general health perceptions domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 General Health Perceptions Domain61.2 score on a scaleStandard Deviation 18.3
Enteral Nutrition + Parenteral NutritionSF36 General Health Perceptions Domain49.5 score on a scaleStandard Deviation 24.3
Secondary

SF-36 Mental Health Index Domain

The SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Mental Health Index Domain66.1 score on a scaleStandard Deviation 22.5
Enteral Nutrition + Parenteral NutritionSF-36 Mental Health Index Domain70.5 score on a scaleStandard Deviation 24.9
Secondary

SF36 Mental Health Index Domain

The SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Mental Health Index Domain72.9 score on a scaleStandard Deviation 18.7
Enteral Nutrition + Parenteral NutritionSF36 Mental Health Index Domain76.1 score on a scaleStandard Deviation 18.5
Secondary

SF-36 Pain Index Domain

The SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Pain Index Domain52.5 score on a scaleStandard Deviation 31
Enteral Nutrition + Parenteral NutritionSF-36 Pain Index Domain68.6 score on a scaleStandard Deviation 28.2
Secondary

SF36 Pain Index Domain

The SF-36 pain index domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Pain Index Domain59.1 score on a scaleStandard Deviation 28.8
Enteral Nutrition + Parenteral NutritionSF36 Pain Index Domain66.4 score on a scaleStandard Deviation 27.3
Secondary

SF-36 Physical Functioning Domain

The SF-36 physical function domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Physical Functioning Domain39.3 score on a scaleStandard Deviation 34
Enteral Nutrition + Parenteral NutritionSF-36 Physical Functioning Domain50.8 score on a scaleStandard Deviation 36.5
Secondary

SF36-Physical Functioning Domain

The SF-36 physical function domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36-Physical Functioning Domain39.4 score on a scaleStandard Deviation 34.3
Enteral Nutrition + Parenteral NutritionSF36-Physical Functioning Domain34.8 score on a scaleStandard Deviation 31.5
Secondary

SF-36 Role-emotional Domain

The SF-36 role-emotional domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Role-emotional Domain52.2 score on a scaleStandard Deviation 41
Enteral Nutrition + Parenteral NutritionSF-36 Role-emotional Domain72.1 score on a scaleStandard Deviation 30.3
Secondary

SF36 Role-emotional Domain

The SF-36 role-emotion domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Role-emotional Domain63.2 score on a scaleStandard Deviation 34.6
Enteral Nutrition + Parenteral NutritionSF36 Role-emotional Domain65.3 score on a scaleStandard Deviation 34.4
Secondary

SF-36 Role-physical Domain

The SF-36 mental health index domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Role-physical Domain40.2 score on a scaleStandard Deviation 33.1
Enteral Nutrition + Parenteral NutritionSF-36 Role-physical Domain47.5 score on a scaleStandard Deviation 33.4
Secondary

SF36 Role Physical Domain

The SF-36 role physical function domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Role Physical Domain30.2 score on a scaleStandard Deviation 31.8
Enteral Nutrition + Parenteral NutritionSF36 Role Physical Domain32.8 score on a scaleStandard Deviation 32.6
Secondary

SF-36 Social Functioning Domain

The SF-36 social functioning domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Social Functioning Domain50.4 score on a scaleStandard Deviation 32.2
Enteral Nutrition + Parenteral NutritionSF-36 Social Functioning Domain68.8 score on a scaleStandard Deviation 32.6
Secondary

SF36 Social Functioning Domain

The SF-36 social functioning domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Social Functioning Domain60.4 score on a scaleStandard Deviation 31.8
Enteral Nutrition + Parenteral NutritionSF36 Social Functioning Domain56.5 score on a scaleStandard Deviation 28.2
Secondary

SF-36 Standardized Mental Component Scale

The SF36 Standardized mental Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Standardized Mental Component Scale43.2 score on a scaleStandard Deviation 14.8
Enteral Nutrition + Parenteral NutritionSF-36 Standardized Mental Component Scale49 score on a scaleStandard Deviation 13.5
Secondary

SF36 Standardized Mental Component Scale

The SF36 Standardized Mental Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Standardized Mental Component Scale50 score on a scaleStandard Deviation 10.5
Enteral Nutrition + Parenteral NutritionSF36 Standardized Mental Component Scale51.5 score on a scaleStandard Deviation 10
Secondary

SF-36 Standardized Physical Component Scale

The SF36 Standardized Physical Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Standardized Physical Component Scale35.8 score on a scaleStandard Deviation 11.2
Enteral Nutrition + Parenteral NutritionSF-36 Standardized Physical Component Scale39.3 score on a scaleStandard Deviation 10.2
Secondary

SF36 Standardized Physical Component Scale

The SF36 Standardized Physical Component Scale has been scaled to have a mean of zero and standard deviation of 10 in a general US population. Higher scores indicate better HRQoL.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Standardized Physical Component Scale35.3 score on a scaleStandard Deviation 10.8
Enteral Nutrition + Parenteral NutritionSF36 Standardized Physical Component Scale33.3 score on a scaleStandard Deviation 10.1
Secondary

SF-36 Vitality Domain

The SF-36 vitality domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF-36 Vitality Domain47.8 score on a scaleStandard Deviation 21.2
Enteral Nutrition + Parenteral NutritionSF-36 Vitality Domain59.1 score on a scaleStandard Deviation 21.7
Secondary

SF36 Vitality Domain

The SF-36 vitality domain ranges from 0-100. Higher scores indicate better outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
EN OnlySF36 Vitality Domain52.8 score on a scaleStandard Deviation 21.4
Enteral Nutrition + Parenteral NutritionSF36 Vitality Domain51 score on a scaleStandard Deviation 21.7

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026